Vicapsys Life Sciences (VICP) Short Interest Ratio & Short Volume $1.51 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Vicapsys Life Sciences Short Interest DataVicapsys Life Sciences (VICP) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 0 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$151.00Short Interest Ratio0.0 Days to CoverLast Record DateAugust 15, 2024Outstanding Shares32,370,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume0 sharesToday's Volume Vs. AverageNaN Short Selling Vicapsys Life Sciences? Sign up to receive the latest short interest report for Vicapsys Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVICP Short Interest Over TimeVICP Days to Cover Over TimeVICP Percentage of Float Shorted Over Time Ad Weiss RatingsWhat is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. Vicapsys Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2024100 shares $151.00 No ChangeN/A0 $1.51 7/31/2024100 shares $151.00 -66.7%N/A1 $1.51 7/15/2024300 shares $1,500.00 -85.7%N/A0.3 $5.00 6/30/20242,100 shares $14,700.00 No ChangeN/A1 $7.00 12/15/2022100 shares $100.00 No ChangeN/A0 $1.00 11/30/2022100 shares $100.00 No ChangeN/A0 $1.00 Get the Latest News and Ratings for VICP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vicapsys Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 11/15/2022100 shares $100.00 No ChangeN/A0 $1.00 10/31/2022100 shares $100.00 No ChangeN/A0 $1.00 10/15/2022100 shares $100.00 No ChangeN/A0 $1.00 9/30/2022100 shares $100.00 No ChangeN/A1 $1.00 9/15/2022100 shares $100.00 No ChangeN/A0 $1.00 8/31/2022100 shares $100.00 -50.0%N/A1 $1.00 8/15/2022200 shares $504.00 No ChangeN/A2 $2.52 7/31/2022200 shares $504.00 No ChangeN/A2 $2.52 7/15/2022200 shares $504.00 No ChangeN/A0 $2.52 6/30/2022200 shares $504.00 No ChangeN/A0 $2.52 6/15/2022200 shares $504.00 No ChangeN/A2 $2.52 5/31/2022200 shares $504.00 No ChangeN/A2 $2.52 5/15/2022200 shares $504.00 No ChangeN/A2 $2.52 4/30/2022200 shares $504.00 No ChangeN/A0.7 $2.52 4/15/2022200 shares $520.00 No ChangeN/A2 $2.60 3/31/2022200 shares $520.00 No ChangeN/A0 $2.60 3/15/2022200 shares $520.00 No ChangeN/A0 $2.60 2/28/2022200 shares $520.00 No ChangeN/A0 $2.60 2/15/2022200 shares $520.00 No ChangeN/A2 $2.60 1/31/2022200 shares $1,000.00 No ChangeN/A0.7 $5.00 VICP Short Interest - Frequently Asked Questions What is Vicapsys Life Sciences' current short interest? Short interest is the volume of Vicapsys Life Sciences shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 100 shares of VICP short. Learn More on Vicapsys Life Sciences' current short interest. How does Vicapsys Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Vicapsys Life Sciences: CytoDyn Inc. (1.02%), Helix BioPharma Corp. (0.00%), Organigram Holdings Inc. (4.60%), Skye Bioscience, Inc. (7.72%), Context Therapeutics Inc. (3.13%), Greenwich LifeSciences, Inc. (7.81%), Mersana Therapeutics, Inc. (6.94%), XBiotech Inc. (4.58%), Shattuck Labs, Inc. (12.86%), Atossa Therapeutics, Inc. (10.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Vicapsys Life Sciences stock? Short selling VICP is an investing strategy that aims to generate trading profit from Vicapsys Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vicapsys Life Sciences? A short squeeze for Vicapsys Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VICP, which in turn drives the price of the stock up even further. How often is Vicapsys Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VICP, twice per month. The most recent reporting period available is August, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CytoDyn Short Squeeze Helix BioPharma Short Squeeze Organigram Short Squeeze Skye Bioscience Short Squeeze Context Therapeutics Short Squeeze Greenwich LifeSciences Short Squeeze Mersana Therapeutics Short Squeeze XBiotech Short Squeeze Shattuck Labs Short Squeeze Atossa Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:VICP) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicapsys Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicapsys Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.